California
|
000-32141
|
91-2021600
|
||
(State or other jurisdiction of
incorporation or organization)
|
(Commission File Number)
|
(IRS Employee Identification
No.)
|
1537
NW 65th
Avenue, Plantation, Florida
|
33313
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code:
|
(954) 509-0911
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
(a)
|
Financial
Statements of Business Acquired
|
Exhibit
|
||
Number
|
Description
|
|
99.1
10.1
|
Financial
Statements of ReceptoPharm
Agreement
and Plan of Merger*
|
|
NUTRA PHARMA CORP.
|
|||
Dated: November
18, 2009
|
By:
|
/s/ Rik J. Deitsch
|
|
Rik J. Deitsch
|
|||
Chairman and Chief Executive Officer
|